• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Rebecca A. Miksad, MD, MPH


  • Miao R, Luo H, Zhou H, Li G, Bu D, Yang X, Zhao X, Zhang H, Liu S, Zhong Y, Zou Z, Zhao Y, Yu K, He L, Sang X, Zhong S, Huang J, Wu Y, Miksad RA, Robson SC, Jiang C, Zhao Y, Zhao H.Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis.J Hepatol. 2014 May 22.
  • Beard RE, Hanto DW, Gautam S, Miksad RA.A comparison of surgical outcomes for noncirrhotic and cirrhotic hepatocellular carcinoma patients in a Western institution.Surgery. 2013 Sep;154(3):545-55.
  • Chan JA, Stuart K, Earle CC, Clark JW, Bhargava P, Miksad R, Blaszkowsky L, Enzinger PC, Meyerhardt JA, Zheng H, Fuchs CS, Kulke MH.Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors.J Clin Oncol. 2012 Aug 20;30(24):2963-8.
  • Miksad RA.When a decision must be made: role of computer modeling in clinical cancer research.J Clin Oncol. 2011 Dec 10;29(35):4602-4.
  • Duvoux C, Kiuchi T, Pestalozzi B, Busuttil R, Miksad R.What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?.Liver Transpl. 2011 Oct;17 Suppl 2:S147-58.
  • Doherty GA, Miksad RA, Cheifetz AS, Moss AC.Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease.Inflamm Bowel Dis. 2011 Sep 8.
  • Mahadevan A, Miksad R, Goldstein M, Sullivan R, Bullock A, Buchbinder E, Pleskow D, Sawhney M, Kent T, Vollmer C, Callery M.Induction Gemcitabine and Stereotactic Body Radiotherapy for Locally Advanced Nonmetastatic Pancreas Cancer.Int J Radiat Oncol Biol Phys. 2011 Jun 8.
  • Zhu AX, Abrams TA, Miksad R, Blaszkowsky LS, Meyerhardt JA, Zheng H, Muzikansky A, Clark JW, Kwak EL, Schrag D, Jors KR, Fuchs CS, Iafrate AJ, Borger DR, Ryan DP.Phase 1/2 study of everolimus in advanced hepatocellular carcinoma.Cancer. 2011 Apr 27.
  • Miksad RA, Lai KC, Dodson TB, Woo SB, Treister NS, Akinyemi O, Bihrle M, Maytal G, August M, Gazelle GS, Swan JS.Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.Oncologist. 2011;16(1):121-32.
  • Geiger-Gritsch S, Stollenwerk B, Miksad R, Guba B, Wild C, Siebert U.Safety of bevacizumab in patients with advanced cancer: a meta-analysis of randomized controlled trials.Oncologist. 2010;15(11):1179-91.
  • Mahadevan A, Jain S, Goldstein M, Miksad R, Pleskow D, Sawhney M, Brennan D, Callery M, Vollmer C.Stereotactic Body Radiotherapy and Gemcitabine for Locally Advanced Pancreatic Cancer.Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):735-42.
  • Zhu AX, Duda DG, Ancukiewicz M, di Tomaso E, Clark JW, Miksad R, Fuchs CS, Ryan DP, Jain RK.Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: Kinetics and potential biomarker value.Clin Cancer Res. 2010 Sep 15.
  • Kamo N, Dandapani SV, Miksad RA, Houlihan MJ, Kaplan I, Regan M, Greenfield TK, Sanda MG.Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the Internet.Ann Oncol. 2010 Aug 17.
  • Miksad RA, Lai KC, Stein MC, Healy ME, Rojas R, Krajewski KM, Zhu AX.Imbalance and gait disturbance from tyrosine kinase inhibition in hepatocellular cancer.J Gastrointest Cancer. 2009;40(3-4):119-22.
  • Wright DR, Wittenberg E, Swan JS, Miksad RA, Prosser LA.Methods for measuring temporary health States for cost-utility analyses.Pharmaco Economics. 2009;27(9):713-23. Review.
  • Swan JS, Miksad RA.Measuring the quality-of-life effects of diagnostic and screening tests.J Am Coll Radiol. 2009 Aug;6(8):567-75.
  • Zhu AX,Sahani DV,Duda DG,di Tomaso E,Ancukiewicz M,Catalano OA,Sindhwani V,Blaszkowsky LS,Yoon SS,Lahdenranta J,Bhargava P,Meyerhardt J,Clark JW,Kwak EL,Hezel AF,Miksad R,Abrams TA,Enzinger PC,Fuchs CS,Ryan DP,Jain RK.Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study.J Clin Oncol. 2009 Jun 20;27(18):3027-35.
  • Miksad RA,Gonen M,Lynch TJ,Roberts TG Jr.Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer.J Clin Oncol. 2009 May 1;27(13):2245-52.
  • Miksad RA,Zietemann V,Gothe R,Schwarzer R,Conrads-Frank A,Schnell-Inderst P,Stollenwerk B,Siebert U.Progression-free survival as a surrogate endpoint in advanced breast cancer.Int J Technol Assess Health Care. 2008 Fall;24(4):371-83.
  • Muhlberger N, Sroczynski G, Esteban E, Mittendorf T, Miksad RA, Siebert U.Cost-effectiveness of primarily human papillomavirus-based cervical cancer screening in settings with currently established Pap screening: A systematic review commissioned by the German Federal Ministry of Health.Int J Technol Assess Health Care. 2008 Spring;24(2):184-92. Review.
  • Molokwu CN, Appelbaum JS, Miksad RA.Detection of prostate cancer following gender reassignment.BJU Int. 2008 Jan;101(2):259; author reply 259-60.
  • Silva G, Miksad R, Freedman SD, Pascual-Leone A, Jain S, Gomes DL, Amancio EJ, Boggio PS, Correa CF, Fregni F.Treatment of cancer pain with noninvasive brain stimulation.J Pain Symptom Manage. 2007 Oct;34(4):342-5.
  • Miksad RA, Schnipper L, Goldstein M.Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?.J Clin Oncol. 2007 Oct 1;25(28):4506-7; author reply 4508.
  • Miksad RA, Bubley G, Church P, Sanda M, Rofsky N, Kaplan I, Cooper A.Prostate cancer in a transgender woman 41 years after initiation of feminization.JAMA. 2006 Nov 15;296(19):2316-7.
  • Costa DB, Miksad RA, Buff MS, Wang Y, Dezube BJ.Case of fatal sickle cell intrahepatic cholestasis despite use of exchange transfusion in an African-American patient.J Natl Med Assoc. 2006 Jul;98(7):1183-7.
  • Levy NC, Miksad RA, Fein OT.From treatment to prevention: the interplay between HIV/AIDS treatment availability and HIV/AIDS prevention programming in Khayelitsha, South Africa.J Urban Health. 2005 Sep;82(3):498-509.
  • Miksad R, de Lédinghen V, McDougall C, Fiel I, Rosenberg H.Hepatic hydrothorax associated with vitamin a toxicity.J Clin Gastroenterol. 2002 Mar;34(3):275-9.